Umoja Biopharma

David Fontana, Ph.D., Chief Operating and Business Officer

April 10 | 3:45pm | Salone dei Cavalieri, Section 2

Seattle, WA


Umioja Biopharma is the leader in in vivo CAR T delivery with its novel platform named VivoVec. As a private company we employ ~170 employees between our Seattle HC and our state of art GMP manufacturing facility in CO. We have recently shared best in field non-human promate data and two of our in vivo products will be in the clinic in 2024. Umoja also has an iPSC platform.

By using this website you agree to accept our Privacy Policy and Terms & Conditions